Dichloromethane → HCID 22941032, compound
Reaction equation
C(OC([NH:8][CH2:9][CH:10]([NH:34][CH2:35][C:36]1[CH:45]=[CH:44][C:43]2[C:38](=[CH:39][CH:40]=[CH:41][CH:42]=2)[CH:37]=1)[CH2:11][N:12]1[CH2:17][CH2:16][N:15]([C:18]([C:20]2[C:29]3[C:24](=[CH:25][CH:26]=[CH:27][CH:28]=3)[CH:23]=[CH:22][CH:21]=2)=[O:19])[CH2:14][C@@H:13]1[CH2:30][CH2:31][CH2:32][CH3:33])=O)(C)(C)C.FC(F)(F)C(O)=O.C(Cl)[Cl:54]>>[ClH:54].[ClH:54].[ClH:54].[NH2:8][CH2:9][CH:10]([NH:34][CH2:35][C:36]1[CH:45]=[CH:44][C:43]2[C:38](=[CH:39][CH:40]=[CH:41][CH:42]=2)[CH:37]=1)[CH2:11][N:12]1[CH2:17][CH2:16][N:15]([C:18]([C:20]2[C:29]3[C:24](=[CH:25][CH:26]=[CH:27][CH:28]=3)[CH:23]=[CH:22][CH:21]=2)=[O:19])[CH2:14][C@@H:13]1[CH2:30][CH2:31][CH2:32][CH3:33]Participants
4
Procedure
A solution of 1-(3-tert-butoxycarbonylamino-2-(2-naphthylmethylamino)prop-1-yl)-2(S)-butyl-4-(1-naphthoyl)piperazine (0.313 g, 0.514 mmol) in methylene chloride (10 mL) was deprotected with trifluoroacetic acid (5 mL) and converted to the free base (255 mg) according to the procedure described in Example 1, Step E. Purification of 40 mg by preparative HPLC used gradient elution with solvents A and B (from Example 1; 95% to 5% solvent A). Ion exchange and lyophilization as described furnished the title compound as a white solid. FAB ms (m+1) 509. Anal. Calc. for C33H40N4O.0.05 H2O 4.45 HCl: C, 59.00; H, 6.68; N, 8.34. Found: C, 59.00; H, 6.51; N, 8.44.
Workup
- customPurification of 40 mg by preparative HPLC
- washelution with solvents A and B (from Example 1; 95% to 5% solvent A)
Sources & evidence
- ORD record
- ord-d79e1ec3037c472bb32d8301e5451d75
- Source dataset
- uspto-grants-1999_01
- Patent number
- US05856326
Reaction notes
Loading…